###begin article-title 0
###xml 34 40 <span type="species:ncbi:10090">murine</span>
Proliferating mesodermal cells in murine embryos exhibiting macrophage and lymphendothelial characteristics
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 371 376 <span type="species:ncbi:10090">mouse</span>
###xml 428 433 <span type="species:ncbi:9031">chick</span>
###xml 540 546 <span type="species:ncbi:10090">murine</span>
###xml 697 703 <span type="species:ncbi:10090">murine</span>
The data on the embryonic origin of lymphatic endothelial cells (LECs) from either deep embryonic veins or mesenchymal (or circulating) lymphangioblasts presently available remain inconsistent. In various vertebrates, markers for LECs are first expressed in specific segments of embryonic veins arguing for a venous origin of lymph vessels. Very recently, studies on the mouse have strongly supported this view. However, in the chick, we have observed a dual origin of LECs from veins and from mesodermal lymphangioblasts. Additionally, in murine embryos we have detected mesenchymal cells that co-express LEC markers and the pan-leukocyte marker CD45. Here, we have characterized the mesoderm of murine embryos with LEC markers Prox1, Lyve-1 and LA102 in combination with macrophage markers CD11b and F4/80.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
We observed cells co-expressing both types of markers (e.g. Prox1 - Lyve-1 - F4/80 triple-positive) located in the mesoderm, immediately adjacent to, and within lymph vessels. Our proliferation studies with Ki-67 antibodies showed high proliferative capacities of both the Lyve-1-positive LECs of lymph sacs/lymphatic sprouts and the Lyve-1-positive mesenchymal cells.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Our data argue for a dual origin of LECs in the mouse, although the primary source of embryonic LECs may reside in specific embryonic veins and mesenchymal lymphangioblasts integrated secondarily into lymph vessels. The impact of a dual source of LECs for ontogenetic, phylogenetic and pathological lymphangiogenesis is discussed.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 587 588 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 589 590 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 686 687 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 744 745 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 853 854 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 933 934 922 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
###xml 844 851 <span type="species:ncbi:9606">infants</span>
The important physiological and pathophysiological roles of the lymphatic vascular system for fluid homeostasis, immune surveillance, inflammation and tumour metastasis justify intensive studies of this hardly visible portion of the vascular system [1,2]. Insufficient development of lymph vessels becomes immediately apparent as lymph oedema, which mostly affects the legs and the genital region of patients. Primary lymph oedema (Nonne-Milroy Syndrome) is caused by mutations in the tyrosine kinase domain of the Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) gene on 5q35.3 [3,4]. Kaposi's sarcoma probably represents a form of lymphatic endothelial cell (LEC) hyperplasia [5], but circulating precursor cells may also be involved [6]. However, it is still not clear whether lymphangioma, which is found in 1.2 - 2.8per thousand of infants [7], is due to hyperplasia of LECs or structural malformations of lymph vessels [8]. These uncertainties with respect to the pathobiology of lymph vessels are based on the fact that the mechanisms of normal embryonic lymphangiogenesis and the origin of LECs are not sufficiently well understood.
###end p 9
###begin p 10
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1167 1169 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1170 1172 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1332 1334 1332 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1522 1524 1522 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1735 1737 1735 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1738 1740 1738 1740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1842 1843 1842 1843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1873 1875 1873 1875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 970 976 <span type="species:ncbi:10090">murine</span>
###xml 1149 1156 <span type="species:ncbi:8355">Xenopus</span>
###xml 1507 1512 <span type="species:ncbi:10090">mouse</span>
###xml 1585 1589 <span type="species:ncbi:10090">mice</span>
###xml 1764 1770 <span type="species:ncbi:9606">humans</span>
Following the identification of specific markers for LECs, our knowledge of the structure and function of lymph vessels and the molecular equipment of LECs has increased enormously in recent years [9,10]. Nevertheless, the embryonic origin of the lymphatic vascular system has been discussed controversially for more than a hundred years, and is still open for discussion. The two main theories are the 'centrifugal' and 'centripetal' theory. The first was set up by Sabin [11,12] and Lewis [13] and proposes a venous origin of the lymph sacs (which are the first clear morphological signs of lymph vessel development), with subsequent sprouting of lymph vessels into all tissues and organs of the body. The second was set up by Huntington and McClure [14] and proposes formation of lymphatic vessels from mesenchymal 'lymphatic clefts', which, nowadays, are called lymphangioblasts. Several recent studies clearly show development of LECs from the venous system in the murine embryo [15-17]. However, an intermediate position favouring a dual origin from embryonic veins and mesenchymal lymphangioblasts was defined by studies on avian embryos and Xenopus tadpoles [18-20]. Migration of mesenchymal lymphangioblasts, which are originally located in the venous system and delaminate from the endothelium, has been observed in fish [21]. Additionally, our previous studies have demonstrated the existence of mesenchymal cells which co-express leukocyte (CD45) and lymphendothelial markers (Prox1, Lyve-1) in mouse embryos [19]. Recent studies on pathological lymphangiogenesis in adult mice have provided evidence of a role of circulating endothelial progenitor cells (CEPCs) and macrophages (CD11b and F4/80 positive) in this process [22-24]. Evidence of CEPCs in humans has been provided in studies on post-transplantation Kaposi's sarcoma [6] and kidney graft rejection [25].
###end p 10
###begin p 11
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
###xml 146 152 <span type="species:ncbi:10090">murine</span>
###xml 693 698 <span type="species:ncbi:10090">mouse</span>
###xml 753 759 <span type="species:ncbi:10090">murine</span>
The detection of cells, which co-express macrophage and lymphendothelial markers in the adult mouse, prompted us to investigate such cells in the murine embryo. We used antibodies against CD31/PECAM-1, a pan-endothelial marker, in combination with LEC-specific markers: Prox1, a homeobox transcription factor, Lyve-1, a hyaluronan receptor, and LA102, a recently defined new epitope on LECs [26]. Double and triple staining were then performed with macrophage markers CD11b and F4/80. These studies, in combination with the proliferation marker Ki-67, provide evidence for the existence of actively dividing mesenchymal cells, which co-express macrophage and lymphendothelial markers in early mouse embryos. The mesenchymal localization of the cells in murine embryos suggests an additional source of LECs, which may integrate into lymph vessels that have primarily originated and sprouted from embryonic veins. The existence of highly mobile (macrophage-like) cells with LEC characteristics seems to be relevant for pathological lymphangiogenesis and inflammation-associated organ rejection [reviews see: [27,28]].
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Cells with pan-endothelial, lymphendothelial and macrophage characteristics
###end title 13
###begin p 14
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 974 978 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A,B</xref>
###xml 115 123 <span type="species:ncbi:405018">cardinal</span>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 488 496 <span type="species:ncbi:405018">cardinal</span>
###xml 807 813 <span type="species:ncbi:10090">murine</span>
###xml 953 961 <span type="species:ncbi:405018">cardinal</span>
During early stages of lymphendothelial commitment, the LEC markers Prox1 and Lyve-1 are expressed by cells of the cardinal veins of the mouse on approximately embryonic day (ED) 9.5 [17]. These cells are also positive for CD31/PECAM-1, a pan-endothelial marker, which is strongly expressed in blood endothelial cells (BECs) and more weakly in LECs [29,30]. The precursor cells give rise to lymph sacs which, in the jugular region, are located in the angle between anterior and posterior cardinal veins [15], as can be demonstrated by staining with anti-Lyve-1 antibodies (Fig. 1). However, the lymph sacs are not the only structures which are Lyve-1-positive. There are large numbers of scattered cells, preferentially located in the loose mesenchyme (Fig. 1A). On ED 13.5 the lymphatic vascular system of murine embryos is made up of a deep and a superficial part. The deep part consists of the lymph sacs located alongside the jugular segment of the cardinal veins (Fig. 1A,B). The superficial lymphatics are located in the dermis. They are connected to the deep system by lymphatic vessels, which are located in the mesenchyme underneath the skeletal elements of the shoulder girdle. Additionally, there are large numbers of scattered Lyve-1-positive cells in the loose mesenchyme of the dermis, the primitive meninges and the parapharyngeal region. The neural tube, skeletal elements and muscles do not contain such cells.
###end p 14
###begin p 15
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Jugular lymph sacs of murine embryos</bold>
###xml 212 214 212 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 289 291 289 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 22 28 <span type="species:ncbi:10090">murine</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 249 257 <span type="species:ncbi:405018">cardinal</span>
###xml 442 450 <span type="species:ncbi:405018">cardinal</span>
Jugular lymph sacs of murine embryos. Lyve-1 staining of paraffin sections (A, B) and double staining of cryo-sections (C-F) of ED 13.5 (A-C, E, F) and 12.5 (D) mice. A, B) The jugular lymph sacs (jls) are Lyve-1+ and located dorso-laterally of the cardinal vein (v). Many scattered Lyve-1+ cells are located superficially in the developing dermis (arrows). nt, neural tube. B) Higher magnification of A showing JLS in close proximity to the cardinal vein. C) Lymph sacs express Prox1 (red) and Lyve-1 (green). D) Prox1 (red) and LA102 (green). E) Lyve-1 (red) and LA102 (green). Note double positive LECs, although staining of lymph sac LECs with LA102 is heterogeneous. F) Lymphatic vessel (arrow) in the dermis is double positive for Lyve-1 and LA102 (yellow).
###end p 15
###begin p 16
###xml 83 85 83 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 95 97 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F</xref>
###xml 260 265 <span type="species:ncbi:10090">mouse</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
Our double staining protocol confirms that LECs of the jugular lymph sacs are Prox1+ and Lyve-1+ (Fig. 1C). The new lymphendothelial marker LA102, a monoclonal antibody recognizing a 25 - 27 kDa protein, specifically reacts with lymphatic vessels of the adult mouse, except for those of the thoracic duct and the marginal sinus of lymph nodes, but not with any blood vessels [26]. We investigated the expression of LA102 during early embryonic lymphangiogenesis of ED 11.5 - 13.5 mice and performed double staining with either Prox1 or Lyve-1. On ED 12.5 and ED 13.5, we observed that LECs in the jugular lymph sacs were double positive for Prox1 and LA102 (Fig. 1D) as well as Lyve-1 and LA102 (Fig. 1E). The same results hold true for the superficial lymphatics of the dermis (Fig. 1F). However, in the mediastinal region, we found some lymphatic vessels which expressed only Lyve-1, while others demonstrated Lyve-1 and LA102 co-expression (data not shown).
###end p 16
###begin p 17
###xml 242 244 242 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 415 417 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 489 490 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 495 497 495 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A,B</xref>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 950 952 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 986 988 986 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1118 1119 1118 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1125 1127 1125 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1173 1175 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 1257 1258 1257 1258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1264 1266 1264 1266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1330 1332 1330 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 1413 1415 1413 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
###xml 1162 1166 <span type="species:ncbi:10090">mice</span>
The data show that all three markers, Prox1, Lyve-1 and LA102 are expressed by LECs of lymph sacs and lymph vessels, although each is also expressed by some non-endothelial cell types. In order to characterize the scattered mesenchymal Lyve-1+ cells shown in Figure 1A, we used double and triple staining with lymph/endothelial and macrophage markers. In our previous studies, we showed that some mesenchymal Lyve-1+ cells co-expressed Prox1 [19]. Here, we detected a small number of Prox1+/CD31+ mesenchymal cells in the dermatomes on ED 10 (Fig. 2A,B). CD31 expression in these cells, which we regard as lymphangioblasts, is lower than in BECs. Co-staining with LA102 and Prox1 antibodies revealed that some scattered cells in the mesenchyme are double positive (Fig. 2C). On ED 12.5 we observed single cells in the mesenchyme surrounding the neural tube which co-expressed Lyve-1 and LA102, but there were also cells only positive for LA102 (Fig. 2D). It has been reported that CD11b+ macrophages may contribute to pathological lymphangiogenesis in the cornea of adult mice [22]. We detected a small number of Prox1+/CD11b+ cells in the mesenchyme of ED 12.5 mice (Fig. 2E). LECs of the jugular lymph sacs on ED 13.5 were CD11b-negative, but a few Lyve-1+/CD11b+ cells were located immediately adjacent to the lymph sacs (Fig. 2F), and appeared to be integrated into the superficial dermal lymph vessels (Fig. 2G).
###end p 17
###begin p 18
###xml 0 175 0 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Double staining of scattered mesodermal cells with pan-endothelial, lymphendothelial and macrophage markers of ED 10 (A, B), ED 12.5 (D, E) and ED 13.5 (C, F, G) mouse embryos</bold>
###xml 413 415 413 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
###xml 275 283 <span type="species:ncbi:405018">cardinal</span>
Double staining of scattered mesodermal cells with pan-endothelial, lymphendothelial and macrophage markers of ED 10 (A, B), ED 12.5 (D, E) and ED 13.5 (C, F, G) mouse embryos. A) Two mesenchymal cells of the dermatome (arrows) which are located at a great distance from the cardinal vein (v) express CD31 (green) and Prox1 (red). nt, neural tube. B) Higher magnification of A). Note weak CD31 expression of Prox1+ mesenchymal cells (arrows) as compared to blood vessels (bv). C) Cells double positive for lymphendothelial markers LA102 (green) and Prox1 (red), and D) LA102 (green) and Lyve-1 (red). E) Cells double positive for macrophage marker CD11b (green) and lymphendothelial marker Prox1 (red). F) Some cells co-express (yellow) CD11b (green) and Lyve-1 (red) in the mesenchyme adjacent to the JLS, and G) in the dermis, where a cell positive for both markers (arrow) seems to be integrated into a lymph vessel (lv).
###end p 18
###begin p 19
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 356 358 356 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 367 369 367 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 409 411 409 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 462 463 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 650 654 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A&#8211;F</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A,B</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 1116 1118 1116 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
###xml 1234 1240 <span type="species:ncbi:10090">murine</span>
We then used the macrophage marker F4/80 for further characterisation of mesenchymal Lyve-1+ cells. A large number of scattered cells of the dermatomes, mediastinum and pimitive meninges co-expressed Lyve-1 and F4/80 in ED 13.5 embryos and some cells expressed only Lyve-1 or F4/80 (Fig. 3). There was a distinct difference between the frequencies of CD11b+ and F4/80+ cells in the mesenchyme. Many more F4/80+ cells could be found, and many of these were Lyve-1+. We, therefore, extended our studies by applying three markers: Prox1, Lyve-1 and F4/80. We found cells in the developing lymph sacs positive for all three markers in ED 13.5 mice (Fig. 4A-F). More peripherally, in developing lymph vessels, we also found a small number of cells positive for all three markers (Fig. 5A,B). In very rare cases, we could observe various marker combinations in adjacent cells of lymph vessels. Figure 5A shows such an example with 3 cells: one positive only for F4/80, one expressing F4/80 and Lyve-1, and a third positive for F4/80, Lyve-1 and Prox1. The fact that two LEC markers, Prox1 and Lyve-1, can be found in F4/80+ cells, which appear to be integrated into lymph vessels, is a strong indication for a mesenchymal source of LECs in murine embryos.
###end p 19
###begin p 20
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F4/80 (green) and Lyve-1 (red) staining of ED 13.5 mice</bold>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
F4/80 (green) and Lyve-1 (red) staining of ED 13.5 mice. Many of the cells in the dermis are double positive (yellow), but some only express F4/80 or Lyve-1.
###end p 20
###begin p 21
###xml 0 126 0 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Double and triple staining of ED 11.5 (A) and ED 13.5 (B &#8211; F) mouse embryos with Prox1 (red), Lyve-1 (blue), and F4/80 (green)</bold>
###xml 396 398 396 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 287 295 <span type="species:ncbi:405018">cardinal</span>
Double and triple staining of ED 11.5 (A) and ED 13.5 (B - F) mouse embryos with Prox1 (red), Lyve-1 (blue), and F4/80 (green). A) Cell showing co-expression of Prox1 and F4/80 (arrow), whereas another cell is only F4/80 positive. B) Overview showing the jugular lymph sac (jls) and the cardinal vein (v). Prox1 and Lyve-1 are co-expressed in LECs of the jls. Arrow indicates integration of F4/80+ cell into the jls. C) Higher magnification of B) showing triple positive cells of the JLS. D) Prox1, E) Lyve-1, F) F4/80.
###end p 21
###begin p 22
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Triple staining of ED 13.5 mouse embryos with Prox1 (red), Lyve-1 (blue), and F4/80 (green)</bold>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Triple staining of ED 13.5 mouse embryos with Prox1 (red), Lyve-1 (blue), and F4/80 (green). A, B) Triple positive cell integrated in a lymphatic vessel (arrow in A and B). A) Cell showing co-expression of Lyve-1 and F4/80 (white arrowhead), whereas another cell is only F4/80 positive (open arrowhead).
###end p 22
###begin title 23
Proliferation studies
###end title 23
###begin p 24
###xml 146 148 146 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0 </sub>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A,B</xref>
###xml 909 911 909 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 999 1000 999 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1038 1040 1038 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1147 1149 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 1190 1192 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 1238 1239 1238 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1287 1289 1287 1289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 594 599 <span type="species:ncbi:10090">Mouse</span>
###xml 651 659 <span type="species:ncbi:405018">cardinal</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
Ki-67 is a well-established proliferation marker and is increasingly expressed in the nucleus in all active phases of the cell cycle, but not in G0 phase [31]. To extend our studies on the source of LECs, we performed double staining with anti-Ki-67 and anti-Lyve-1 antibodies of ED 11.5 - 13.5 mice. Nuclei were counter stained with 4',6-diamidino-2-phenylindol (DAPI). Double positive LECs could be detected in regions of active lymphangiogenesis: the early jugular veins, the jugular lymph sacs, which extended sprouts into dorso-lateral directions, the mediastinum and the dermis (Fig. 6). Mouse embryos on ED 11.5 exhibited very few cells in the cardinal veins positive for both markers, whereas LECs of the developing jugular lymph sacs as well as mesenchymal cells in the dermis co-expressed Ki-67 and Lyve-1 at high rates (Fig. 6A,B). The dermatomes of ED 12.5 and 13.5 mice displayed scattered Lyve-1+ cells, which also showed proliferating characteristics (55% and 33%, respectively; Fig. 7). However, the total number of Lyve-1+ cells in the dermatomes was low compared with the number of lymph sac ECs. In the jugular lymph sacs (Fig. 6C) and in sprouts derived from them (Fig. 6D) the Ki-67 labelling rate was 22 - 30% (Fig. 7). The data show that a greater number of Lyve-1+ cells are present in the lymph sacs than in the dermatomes, but the latter proliferate at equal or, in ED 12.5 embryos, even higher rates.
###end p 24
###begin p 25
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Paraffin sections of mouse embryos stained with antibodies against Ki-67 (green) and Lyve-1 (red)</bold>
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 281 289 <span type="species:ncbi:405018">cardinal</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
Paraffin sections of mouse embryos stained with antibodies against Ki-67 (green) and Lyve-1 (red). Counter staining was performed with DAPI (blue). A) On ED 11.5, there are proliferating LECs in the developing jugular lymph sacs (jls) (arrows), but no double positive cells in the cardinal vein (v). B) Two mesenchymal cells positive for the markers located in the dermatome (arrows). g, spinal ganglion. C) JLS of ED 12.5 mice with LECs (arrows) expressing Ki-67 and Lyve-1. D) Sprout from the JLS containing proliferating cells (arrows). Inset: Higher magnification showing Ki-67-positive (arrow) and negative (arrowhead) LECs.
###end p 25
###begin p 26
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Proliferation studies of Lyve-1<sup>+ </sup>cells with Ki-67 antibodies in ED 12.5 and ED 13.5 mice</bold>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
Proliferation studies of Lyve-1+ cells with Ki-67 antibodies in ED 12.5 and ED 13.5 mice. For each ED, at least 5 sections of at least 3 mice were evaluated. The total number of cells counted was: 197 in lymph sacs (LS) on ED 12.5; 406 in lymph sacs (LS) on ED 13.5; 45 in sprouts from lymph sacs (Sp) on ED 12.5; 75 in sprouts from lymph sacs (Sp) on ED 13.5; 43 in scattered cells in the dermatomes (D) on ED 12.5 and 40 in scattered cells in the dermatomes (D) on ED13.5. Mean and standard deviation are shown. The value for D 12.5 is significantly higher than all others.
###end p 26
###begin title 27
Discussion
###end title 27
###begin title 28
Embryonic lymphangiogenesis
###end title 28
###begin p 29
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 139 140 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Our data show that there is a cell type in early mouse development, which combines lymphendothelial (Lyve-1+, Prox1+) and macrophage (F4/80+) characteristics. Also, there are cells that express Lyve-1 and F4/80, as well as cells that have only one of these markers. The triple-positive cells appear to be integrated into the lining of early lymph vessels, and, in sum, the data are in favour of an origin of LECs from mesenchymal, macrophage-like cells. Although these cells may contribute only to the minor part of the lymphovascular system, their existence and possible contribution to pathological lymphangiogenesis should not be neglected.
###end p 29
###begin p 30
###xml 34 36 34 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1152 1157 1152 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 1221 1223 1221 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1384 1390 1384 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 1400 1402 1400 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 172 180 <span type="species:ncbi:405018">cardinal</span>
###xml 400 408 <span type="species:ncbi:405018">cardinal</span>
###xml 612 620 <span type="species:ncbi:405018">cardinal</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1328 1333 <span type="species:ncbi:10090">mouse</span>
###xml 1513 1517 <span type="species:ncbi:10090">mice</span>
Recent data by Srinivasan et al. [15] have provided clear evidence that the major part of the lymphovascular system of mice is of venous origin. The jugular segment of the cardinal veins is the source of the jugular lymph sacs, which then grow into peripheral parts of the body. Prox1-expressing venous ECs are the source of the jugular lymph sacs in the anterior region of the embryo. The posterior cardinal veins give rise to the posterior lymph sacs, which are the source of the lymphatics in the mesenteries and the posterior organs. The earliest Prox1-positive ECs are located in the jugular segment of the cardinal veins of ED 9.75 mice. A third place of origin of lymphatics is the orbital region [15]. Loss of Prox1 expression abolishes development of lymphatics [17]. Regular development of veins is another prerequisite for the generation of LECs. The absence of Coup-TFII, an orphan nuclear receptor transcription factor, causes embryonic death around ED 10, abnormal expression of arterial marker genes in the veins, and loss of jugular lymph sacs [15,32-36]. A contribution of hematopoietic cells to the lymphatics does not seem to exist. Runx1-null mice, which do not develop definitive hematopoietic cell [37], have normal jugular lymph sacs, and descendents of hematopoietic stem cells are not detectable in the mouse carrying a reporter gene under the control of the Runx1 promoter [15]. In all, these data show that the venous system is the main source of the embryonic lymphovascular system in mice.
###end p 30
###begin p 31
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 800 804 800 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Syk </italic>
###xml 808 815 808 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slp-76 </italic>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1080 1084 1080 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Syk </italic>
###xml 1088 1095 1088 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slp-76 </italic>
###xml 1337 1339 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1349 1353 1349 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Syk </italic>
###xml 1357 1364 1357 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slp-76 </italic>
###xml 1494 1498 1494 1498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Syk </italic>
###xml 1502 1509 1502 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slp-76 </italic>
###xml 1593 1595 1593 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 390 405 <span type="species:ncbi:10090">transgenic mice</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 901 906 <span type="species:ncbi:10090">Mouse</span>
Nevertheless, even the highly detailed studies on the venous origin of embryonic LECs cannot rule out the possibility of a minor contribution of mesenchymal cells to the lymphatics [15,17]. In both of the studies cited, scattered Prox1-positive cells were observed along the anteroposterior axis of the body wall of early embryos - at great distances from the developing lymph sacs. In the transgenic mice studied by Srinivasan et al. [15] some cells were detected, which did not fit into the anticipated pattern of the venous origin of LECs. Thus, there are some observations that argue for an additional source of LECs. The number of LECs derived from macrophage-like, mesenchymal precursors may be low, but that does not necessarily rule out functional importance. This is supported by studies on Syk and Slp-76 knockout mice. These adapter proteins mediate outside-in integrin signalling [38,39]. Mouse embryos lacking Syk and Slp-76 functions develop abnormal blood-lymph-endothelial connections, and Slp-76 deficient cells confer this phenotype on chimeric embryos [40,41]. Syk and Slp-76 are expressed in hematopoietic cells, but not in ECs. The incorporation of defective cells into abnormally fused lymph vessels and the rescue of the phenotype by GFPSlp-67-expressing circulating cells indicate a hematopoietic origin of LECs [40]. Normal Syk and Slp-76 functions may be required in early stages of development, when hemangioblasts divide into hematopoietic and endothelial lineages. Syk and Slp-76 are expressed by platelets and eosinophils, but not macrophages or dendritic cells [40].
###end p 31
###begin p 32
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
Incorporation of macrophages into lymph vessels has been indicated by studies on pathological lymphangiogenesis [22-24]. Our studies strongly suggest that similar mechanisms are found in embryonic lymphangiogenesis. In the adult, macrophages originate from circulating monocytes, but, in the embryo, their early development in the mesoderm is independent of the hematopoietic system. They can be isolated from the epiblast before gastrulation. So, they are present before the development of hematopoietic cells in blood islands [42]. After gastrulation, macrophages are found in all embryonic compartments, which is also evident in the studies presented here. Mesenchymal macrophages can give rise to stationary cells, which is best documented in the central nervous system (CNS) where they form the microglia [43], which has self-renewal potential. Our studies provide initial evidence for the incorporation of macrophage-like cells into the lining of lymph vessels during normal development.
###end p 32
###begin p 33
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 812 814 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 835 837 835 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 906 907 906 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1270 1272 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 69 75 <span type="species:ncbi:10090">murine</span>
###xml 414 419 <span type="species:ncbi:10090">mouse</span>
###xml 735 740 <span type="species:ncbi:9031">chick</span>
There are large numbers of Lyve-1+ single cells in the mesenchyme of murine embryos, which are highly proliferative and obviously represent a heterogeneous cell population. Many of the cells express the pan-leukocyte marker CD45 [19]. Here, we show that some of the cells co-express other LEC markers such as Prox1 and LA102. Co-localization of Prox1 and CD31/PECAM-1 in scattered cells in the dermatomes of ED 10 mouse embryos is a strong indicator of a lymphangioblastic cell population. Prox1 is the most reliable marker that distinguishes between LECs and BECs in healthy and diseased tissues [29,30], and CD31 is a highly reliable pan-endothelial marker. In birds, similar cells are present, and grafting of quail dermatomes into chick embryos has demonstrated the lymphangiogenic potential of this tissue [20]. Many of the Lyve-1+ single cells in the mesenchyme express F4/80, but only some are CD11b+. The F4/80 antibody recognises an extra-cellular membrane molecule, highly restricted to mature macrophage subpopulations. The antigen is not present on granulocytes, lymphocytes, mast cells, platelets, endothelial cells and blood monocytes [44]. CD11b is found on 'classical' macrophages such as alveolar and peritoneal macrophages, but not on dendritic cells [45]. We detected a small number of Prox1-Lyve-1-F4/80 triple-positive cells, which were obviously integrated into the lining of lymph vessels. Although this is a rare event, it demonstrates heterogeneity of LECs, probably due to heterogeneity of lymphangiogenic mechanisms, which may be relevant not only during embryonic lymphangiogenesis, but also in phylogeny and during pathological lymphangiogenesis.
###end p 33
###begin title 34
Phylogenetic lymphangiogenesis
###end title 34
###begin p 35
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 405 416 405 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 799 809 799 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1192 1194 1192 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1195 1197 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1198 1200 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 405 415 <span type="species:ncbi:7227">Drosophila</span>
###xml 799 809 <span type="species:ncbi:7227">Drosophila</span>
Development of LECs from macrophage-like progenitors might reflect an ancestral mechanism. This assumption is based on the observation that insects, which do not possess ECs [46], have macrophages that express ancestors of typical angiogenesis-associated molecules of vertebrates [47-49]. The tubular heart (also called dorsal vessel) of insects is lined by contractile muscle cells, but not ECs [46]. In Drosophila supply with oxygen is accomplished by a tracheal system. Red blood cells are not present and the so-called hemolymphatic system fulfils functions of a typical lymphatic system. It has, therefore, been speculated that the lymphovascular system evolved before the blood vascular system, although during ontogeny the latter develops first [50]. Three types of immune cells are found in Drosophila: plasmatocytes, crystal cells and lamellocytes [51]. Plasmatocytes, which are capable of phagocytosis, are comparable to the monocyte/macrophage lineage of vertebrates. They possess a single ancestor for the VEGF (Vascular Endothelial Growth Factor) and PDGF (Platelet-derived Growth Factor) receptors found in vertebrates. This receptor, called PVR, directs immune cell migration [48,49,52]. The VEGF-PDGF-system is indispensable for the development of vessels in vertebrates (ECs, pericytes, smooth muscle cells), and it is tempting to speculate that vascular wall cells are derived from macrophage-like cells during phylogeny, and some LECs still do so during ontogeny.
###end p 35
###begin title 36
Pathological lymphangiogenesis
###end title 36
###begin p 37
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 1130 1131 1130 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 695 700 <span type="species:ncbi:10090">mouse</span>
###xml 1104 1110 <span type="species:ncbi:10090">murine</span>
Lymphangiogenesis in embryos and adult organisms have many mechanisms in common, but they may also differ to some extent. Lymphangiogenesis in the adult takes place in the proliferation phase of the endometrium [53]. Pathological lymphangiogenesis can be observed in inflammatory diseases such as Crohn's disease and ulcerative colitis [54], in and around tumours that express the lymphangiogenic growth factors VEGF-C and -D [55-57], and during wound healing, where it occurs after blood vessels have formed [58]. In these scenarios, new lymphatics are mostly formed from pre-existing ones, however, exceptions have been observed. One of these exceptions is the healing of dermal wounds in the mouse tail [59]. In this model, LECs do not sprout from lymph vessels, but migrate as single cells from distal to proximal parts of the tail and organize into vessels in the direction of interstitial fluid flow. It is tempting to speculate that the dermis of adult organisms still contains lymphendothelial precursor cells, which is in line with our observation of lymphangioblasts in the early dermatomes of murine and avian embryos [2,19].
###end p 37
###begin p 38
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 427 428 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 440 441 440 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 581 587 <span type="species:ncbi:10090">murine</span>
Macrophages may support pathological lymphangiogenesis in two ways: either by transdifferentiation and direct incorporation into the endothelial layer or by stimulating division of pre-existing local LECs [22,23,60]. Thereby, VEGF-C seems to have a dual role as inducer of LEC proliferation and chemoattractant of macrophages [61]. In diabetes, wound healing is impaired, due to decreased numbers of macrophages (F4/80+, Lyve-1+, podoplanin+) and lymph vessels [62]. A pool of macrophages expressing VEGFR-3, CD45 and CD11b has been found in the conjunctiva of normal and inflamed murine eyes [63]. However, further studies are needed to clarify whether their incorporation into lymph vessels is permanent or represents some kind of lymphendothelial mimicry [24].
###end p 38
###begin p 39
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 1222 1223 1222 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1436 1437 1436 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1710 1712 1710 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
###xml 644 649 <span type="species:ncbi:9606">human</span>
###xml 1700 1708 <span type="species:ncbi:9606">patients</span>
Evidence for circulating cells with lymphendothelial characteristics has been found in human diseases. In patients with gender-mismatched renal transplants and inflammation-associated transplant rejection, Kerjaschki et al. [25] observed lymphangiogenesis with Ki-67 labelling rates of 2.3% of LECs, and incorporation of circulating recipient-derived cells into kidney lymph vessels in the range of 2.7 - 7%. The Ki-67 labelling rates are clearly lower than those we observed in embryonic LECs (in the mouse), whereas the incorporation of circulating progenitor cells into the lining of lymph vessels appears to be relatively high in the adult human. The second disease, which shows involvement of circulating lymphatic progenitor cells, is Kaposi's sarcoma (KS). The cell of origin in KS has long been a subject of debate. Mesenchymal cells, smooth muscle cells, BECs, LECs, Schwann cells and fibroblasts have been discussed. An endothelial origin has then been favoured, but it has remained unclear whether these are BECs or LECs [64,65]. Studies on the expression of lymphendothelial markers VEGFR-3, podoplanin and Lyve-1, and studies showing the mitogenic effect of VEGF-C seem to prove that KS is derived from LECs [5]. However, examination of biopsies from KS skin lesions, which developed after transplantation in immuno-suppressed recipients of kidneys, showed that a high proportion of KS cells were of donor (kidney) origin [6]. These findings suggest that KS cells are derived from highly mobile cells. It is probable that these are macrophage-like, which originated in the donor organ. Cells with macrophage and endothelial characteristics have been isolated from peripheral blood of KS patients [66].
###end p 39
###begin title 40
Conclusion
###end title 40
###begin p 41
###xml 98 104 <span type="species:ncbi:10090">murine</span>
###xml 340 345 <span type="species:ncbi:10090">mouse</span>
###xml 353 358 <span type="species:ncbi:9606">human</span>
In summary, we describe mesenchymal cells with macrophage and lymphendothelial characteristics in murine embryos. These cells seem to participate in normal lymphangiogenesis and might represent a relict of the phylogenetic development of lymph vessels from immune cells. Similar cells may take part in pathological lymphangiogenesis in the mouse and in human beings, and may be the cell of origin in Kaposi's sarcoma.
###end p 41
###begin title 42
Methods
###end title 42
###begin title 43
Animals
###end title 43
###begin p 44
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
NMRI and C57BL/6 wild type mouse embryos from ED 10 to 13.5 were studied. Embryos were removed from the uterus and remained either unfixed, or were fixed in 4% paraformaldehyde (PFA), or in 100% ethanol containing 3% acetic acid. We did not observe any differences between the two strains.
###end p 44
###begin title 45
Immunohistochemistry
###end title 45
###begin p 46
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 167 173 <span type="species:ncbi:9986">rabbit</span>
###xml 179 184 <span type="species:ncbi:10090">mouse</span>
###xml 280 284 <span type="species:ncbi:9925">goat</span>
###xml 290 296 <span type="species:ncbi:9986">rabbit</span>
Mouse embryos were embedded in paraffin and sectioned into 8 mum slices with a microtome (Leica, Bensheim, Germany) and placed onto slides. Sections were stained with rabbit-anti-mouse Lyve-1 antibodies (Regeneron, Tarrytown, NY). The secondary antibody was peroxidase-conjugated goat-anti-rabbit IgG (Sigma-Aldrich, Taufkirchen, Germany). Diaminobenzidine was used as chromogen. Sections were counter stained with nuclear fast red.
###end p 46
###begin title 47
Proliferation studies
###end title 47
###begin p 48
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 36 42 <span type="species:ncbi:9986">rabbit</span>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 255 259 <span type="species:ncbi:9925">goat</span>
###xml 265 268 <span type="species:ncbi:10116">rat</span>
###xml 299 303 <span type="species:ncbi:9925">goat</span>
###xml 309 315 <span type="species:ncbi:9986">rabbit</span>
Paraffin sections were stained with rabbit-anti-mouse Lyve-1 antibodies [67,68] and Ki-67 (Dako, Hamburg, Germany). The Ki-67-antigen was used with citrate buffer in the microwave oven for antigen retrieval. The secondary antibodies, Alexa 488-conjugated goat-anti-rat IgG, and Alexa 594-conjugated goat-anti-rabbit IgG (Molecular Probes, Eugene, US), were applied at a dilution of 1:200, for 1 hour (h). Sections were counter-stained with DAPI.
###end p 48
###begin title 49
Immunofluorescence
###end title 49
###begin p 50
###xml 1187 1189 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 375 381 <span type="species:ncbi:9913">bovine</span>
###xml 544 550 <span type="species:ncbi:9986">rabbit</span>
###xml 556 561 <span type="species:ncbi:10090">mouse</span>
###xml 597 600 <span type="species:ncbi:10116">rat</span>
###xml 606 611 <span type="species:ncbi:10090">mouse</span>
###xml 663 669 <span type="species:ncbi:9986">rabbit</span>
###xml 675 680 <span type="species:ncbi:9606">human</span>
###xml 730 733 <span type="species:ncbi:10116">rat</span>
###xml 739 744 <span type="species:ncbi:10090">mouse</span>
###xml 783 786 <span type="species:ncbi:10116">rat</span>
###xml 792 797 <span type="species:ncbi:10090">mouse</span>
###xml 842 845 <span type="species:ncbi:10116">rat</span>
###xml 851 856 <span type="species:ncbi:10090">mouse</span>
###xml 917 920 <span type="species:ncbi:10116">rat</span>
###xml 926 931 <span type="species:ncbi:10090">mouse</span>
###xml 1253 1257 <span type="species:ncbi:9925">goat</span>
###xml 1263 1266 <span type="species:ncbi:10116">rat</span>
###xml 1296 1300 <span type="species:ncbi:9925">goat</span>
###xml 1306 1312 <span type="species:ncbi:9986">rabbit</span>
###xml 1406 1410 <span type="species:ncbi:9925">goat</span>
###xml 1416 1422 <span type="species:ncbi:9986">rabbit</span>
Embryos of various developmental stages remained unfixed or were fixed in 4% PFA for 20 minutes. They were rinsed in phosphate-buffered saline (PBS), transferred to 5% and 15% sucrose in PBS, and embedded in Tissue Freeze Medium (Sakura Finetek Europe, NL). Cryosections of 20 mum thickness were prepared. Non-specific binding of antibodies was blocked by incubation with 1% bovine serum albumin (BSA) for 1 h before incubation with the primary antisera. The following primary antibodies were used in this study for double and triple staining: rabbit-anti-mouse LYVE-1 (Regeneron, Tarrytown, NY), rat-anti-mouse CD31/PECAM-1 (1:50; BD Pharmingen, San Diego, US), rabbit-anti-human Prox1 (1:750; ReliaTech, Braunschweig, Germany), rat-anti-mouse Ki-67 (1:50; Dako, Hamburg, Germany), rat-anti-mouse CD11b (1:50; BD Pharmingen, San Diego, US), rat-anti-mouse F4/80 (1:100; Hycult Biotechnology, Uden, Netherlands), and rat-anti-mouse LA102 (pure supernatant, T. Ezaki, Japan). The sections were incubated with the primary antibodies for 1 h, except for Prox1, which was incubated overnight. In the negative controls, the primary antibody was omitted. Typical controls have been published [19]. After having been rinsed, the secondary Alexa 488-conjugated goat-anti-rat IgG and Alexa 594-conjugated goat-anti-rabbit IgG (Molecular Probes, Eugene, US) were applied at a dilution of 1:200. Alexa 350-conjugated goat-anti-rabbit IgG (Molecular Probes) was applied at 1:50 for 1 h. After having been rinsed, the sections were mounted under cover slips with Fluoromount-G (Southern Biotechnology Associates, Birmingham, GB). They were then viewed with the DM5000B epifluorescence microscope (Leica, Bensheim, Germany) and Zeiss Axioplan 2 LSM 510 (Zeiss, Gottingen, Germany).
###end p 50
###begin title 51
Authors' contributions
###end title 51
###begin p 52
KB carried out immunostaining and was involved in the analysis of data and preparation of the manuscript. TE performed immunostaining with lymphendothelial marker LA102. JW conceived the study and participated in its design, data analysis and manuscript preparation.
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
We thank Mrs. C. Maelicke for copy-editing the manuscript. This study was supported by a grant (Wi 1452/11-1) from the Deutsche Forschungsgemeinschaft.
###end p 54
###begin article-title 55
Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology
###end article-title 55
###begin article-title 56
Development of lymphatic vessels: tumour lymphangiogenesis and lymphatic invasion
###end article-title 56
###begin article-title 57
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
###end article-title 57
###begin article-title 58
Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase
###end article-title 58
###begin article-title 59
The lymphatic biology of Kaposi's sarcoma
###end article-title 59
###begin article-title 60
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors
###end article-title 60
###begin article-title 61
Hemangiomas, cystic hygromas, and teratomas of the head and neck
###end article-title 61
###begin article-title 62
###xml 36 43 <span type="species:ncbi:9606">patient</span>
TIE2 gain-of-function mutation in a patient with pancreatic lymphangioma associated with blue rubber-bleb nevus syndrome: report of a case
###end article-title 62
###begin article-title 63
Genesis and pathogenesis of lymphatic vessels
###end article-title 63
###begin article-title 64
###xml 37 42 <span type="species:ncbi:9606">human</span>
Lymphangiogenesis in development and human disease
###end article-title 64
###begin article-title 65
###xml 118 121 <span type="species:ncbi:9823">pig</span>
On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig
###end article-title 65
###begin article-title 66
###xml 24 29 <span type="species:ncbi:9606">human</span>
The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole
###end article-title 66
###begin article-title 67
###xml 43 50 <span type="species:ncbi:9986">Rabbits</span>
The development of the lymphatic system in Rabbits
###end article-title 67
###begin article-title 68
###xml 61 73 <span type="species:ncbi:9685">domestic cat</span>
The anatomy and development of the jugular lymph sacs in the domestic cat (Felis domestica)
###end article-title 68
###begin article-title 69
Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature
###end article-title 69
###begin article-title 70
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
###end article-title 70
###begin article-title 71
###xml 54 60 <span type="species:ncbi:10090">murine</span>
Prox1 function is required for the development of the murine lymphatic system
###end article-title 71
###begin article-title 72
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
###xml 14 21 <span type="species:ncbi:8355">Xenopus</span>
Zebrafish and Xenopus tadpoles: small animal models to study angiogenesis and lymphangiogenesis
###end article-title 72
###begin article-title 73
###xml 73 79 <span type="species:ncbi:10090">murine</span>
Mesenchymal cells with leukocyte and lymphendothelial characteristics in murine embryos
###end article-title 73
###begin article-title 74
Dual origin of avian lymphatics
###end article-title 74
###begin article-title 75
###xml 45 54 <span type="species:ncbi:7955">zebrafish</span>
Live imaging of lymphatic development in the zebrafish
###end article-title 75
###begin article-title 76
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages
###end article-title 76
###begin article-title 77
Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels
###end article-title 77
###begin article-title 78
Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis
###end article-title 78
###begin article-title 79
###xml 82 87 <span type="species:ncbi:9606">human</span>
Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants
###end article-title 79
###begin article-title 80
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Production of two novel monoclonal antibodies that distinguish mouse lymphatic and blood vascular endothelial cells
###end article-title 80
###begin article-title 81
Characteristics of lymphatic endothelial cells in physiological and pathological conditions
###end article-title 81
###begin article-title 82
Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players
###end article-title 82
###begin article-title 83
Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas
###end article-title 83
###begin article-title 84
###xml 98 103 <span type="species:ncbi:9606">human</span>
The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues
###end article-title 84
###begin article-title 85
The Ki-67 protein: from the known and the unknown
###end article-title 85
###begin article-title 86
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse lacking COUP-TFII as an animal model of Bochdalek-type congenital diaphragmatic hernia
###end article-title 86
###begin article-title 87
Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity
###end article-title 87
###begin article-title 88
###xml 116 120 <span type="species:ncbi:10116">rats</span>
Superoxide dismutase, catalase and glutathione peroxidase activities in the lymphoid organs and skeletal muscles of rats treated with dexamethasone
###end article-title 88
###begin article-title 89
###xml 106 119 <span type="species:ncbi:42337">Bidens pilosa</span>
Immunosuppressive and anti-inflammatory effects of methanolic extract and the polyacetylene isolated from Bidens pilosa L
###end article-title 89
###begin article-title 90
The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development
###end article-title 90
###begin article-title 91
###xml 59 64 <span type="species:ncbi:9606">human</span>
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
###end article-title 91
###begin article-title 92
The molecular adapter SLP-76 relays signals from platelet integrin alphaIIbbeta3 to the actin cytoskeleton
###end article-title 92
###begin article-title 93
Syk is required for integrin signaling in neutrophils
###end article-title 93
###begin article-title 94
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development
###end article-title 94
###begin article-title 95
Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk
###end article-title 95
###begin article-title 96
###xml 74 77 <span type="species:ncbi:9823">pig</span>
Continuous cultures of macrophages derived from the 8-day epiblast of the pig
###end article-title 96
###begin article-title 97
Embryonic CNS macrophages and microglia do not stem from circulating, but from extravascular precursors
###end article-title 97
###begin article-title 98
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
A monoclonal antibody against an antigen present on mouse macrophages and absent from monocytes
###end article-title 98
###begin article-title 99
Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets
###end article-title 99
###begin article-title 100
###xml 27 37 <span type="species:ncbi:7227">Drosophila</span>
Cell fate decisions in the Drosophila dorsal vessel depend on the multiadapter protein inscuteable
###end article-title 100
###begin article-title 101
###xml 60 70 <span type="species:ncbi:7227">Drosophila</span>
Guidance of cell migration by EGF receptor signaling during Drosophila oogenesis
###end article-title 101
###begin article-title 102
###xml 34 44 <span type="species:ncbi:7227">Drosophila</span>
Guidance of cell migration by the Drosophila PDGF/VEGF receptor
###end article-title 102
###begin article-title 103
###xml 4 14 <span type="species:ncbi:7227">Drosophila</span>
The Drosophila VEGF receptor homolog is expressed in hemocytes
###end article-title 103
###begin article-title 104
The lymphatic vascular system: secondary or primary?
###end article-title 104
###begin article-title 105
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila blood cells
###end article-title 105
###begin article-title 106
###xml 53 63 <span type="species:ncbi:7227">Drosophila</span>
Developmental control of blood cell migration by the Drosophila VEGF pathway
###end article-title 106
###begin article-title 107
Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma
###end article-title 107
###begin article-title 108
Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease
###end article-title 108
###begin article-title 109
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
###end article-title 109
###begin article-title 110
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
###end article-title 110
###begin article-title 111
###xml 22 27 <span type="species:ncbi:9606">human</span>
Active interaction of human A375 melanoma cells with the lymphatics in vivo
###end article-title 111
###begin article-title 112
Lymphatic endothelium: morphological, molecular and functional properties
###end article-title 112
###begin article-title 113
Characterization of lymphangiogenesis in a model of adult skin regeneration
###end article-title 113
###begin article-title 114
Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis
###end article-title 114
###begin article-title 115
Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma
###end article-title 115
###begin article-title 116
Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing
###end article-title 116
###begin article-title 117
Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva
###end article-title 117
###begin article-title 118
Kaposi's sarcoma. Origin and significance of lymphaticovenous connections
###end article-title 118
###begin article-title 119
The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin
###end article-title 119
###begin article-title 120
###xml 143 151 <span type="species:ncbi:9606">patients</span>
Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients
###end article-title 120
###begin article-title 121
LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
###end article-title 121
###begin article-title 122
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium
###end article-title 122

